Provided by Tiger Trade Technology Pte. Ltd.

Exagen

4.58
-0.0600-1.29%
Post-market: 4.580.00000.00%17:05 EDT
Volume:404.58K
Turnover:1.91M
Market Cap:110.16M
PE:-5.20
High:5.01
Open:4.73
Low:4.53
Close:4.64
52wk High:12.23
52wk Low:2.59
Shares:24.05M
Float Shares:15.92M
Volume Ratio:2.08
T/O Rate:2.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8813
EPS(LYR):-0.9300
ROE:-193.58%
ROA:-19.13%
PB:7.63
PE(LYR):-4.92

Loading ...

Exagen Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 10

Exagen FY2025 net loss widens 32% to USD 19.95 million on revenue up 20% to USD 66.58 million

Reuters
·
Mar 10

Exagen Q4 revenue slightly beats expectations

Reuters
·
Mar 10

Exagen Q4 EPS $(0.20) Misses $(0.18) Estimate, Sales $16.631M Beat $16.567M Estimate.

Benzinga
·
Mar 10

BRIEF-Exagen Inc. Q4 Revenue USD 16.631 Million Vs. IBES Estimate USD 16.6 Million

Reuters
·
Mar 10

Exagen Inc. Q4 Net Income USD -4.673 Million

THOMSON REUTERS
·
Mar 10

Exagen Inc. Q4 Revenue USD 16.631 Million VS. Ibes Estimate USD 16.6 Million

THOMSON REUTERS
·
Mar 10

Exagen Inc. Q4 Operating Expenses USD 14.181 Million

THOMSON REUTERS
·
Mar 10

Exagen Inc. Outlook FY Revenue USD 70-73 Million VS. Ibes Estimate USD 73.8 Million

THOMSON REUTERS
·
Mar 10

Exagen Inc. Q4 EPS USD -0.2

THOMSON REUTERS
·
Mar 10

Exagen Inc - Expects Full-Year 2026 Revenue of $70 Mln to $73 Mln

THOMSON REUTERS
·
Mar 10

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results

GlobeNewswire
·
Mar 10

U.S. Earnings Preview: Before Market Open March 10

Dow Jones
·
Mar 10

Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Mar 06

Exagen Inc. to Participate in KeyBank Capital Markets Healthcare Forum and Roth Capital Conference

Reuters
·
Mar 03

Exagen Inc. to Report Fourth-Quarter and Full-Year 2025 Financial Results and Host Conference Call

Reuters
·
Feb 24

Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

GlobeNewswire
·
Feb 24

BTIG Sticks to Their Buy Rating for Exagen (XGN)

TIPRANKS
·
Feb 17

Exagen Is Maintained at Buy by BTIG

Dow Jones
·
Feb 17

B. Riley Cuts Price Target on Exagen to $8 From $18, Keeps Buy Rating

MT Newswires Live
·
Jan 30